WNT1 AS A RENAL DAMAGE BIOMARKER

摘要

The present invention comprises the use of WNT1 as a biomarker in the monitoring, prognosis and /or in the diagnosis of chronic nephropathies. It provides in vitro prognostic and diagnostic methods and kits for its implementation. The present invention also comprises the use of WNT1 in screening active ingredients for the manufacture of a drug for therapies for chronic nephropathies and a method for conducting said screening.